Werewolf Therapeutics, Inc. (HOWL:NASDAQ) closed at $0.980 on October 16, 2026, down 1.71% on the day. The stock trades 46.4% below its 52-week high of $1.83 and 263.0% above its 52-week low of $0.270. Over the past year, it lost 38.8%. Werewolf Therapeutics, Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -0.18% | +1.77% | +166.30% | +1.03% | -38.75% |
In 252 trading sessions since October 16, 2025, HOWL closed higher on 116 days (46%). Its best day was August 21, 2026 (+102.78%) and its worst was December 18, 2025 (-39.53%). The stock moved 10% or more in a single session 21 times. It opened at least 5% above the previous day's high 1 time.
Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.
Find more stocks like HOWL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.